Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02943941 · ClinicalTrials.gov registry record · NA
Pressure Variability Study
A NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT02943941: Completed NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT02943941 is a NA study of Heart Failure that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 16 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02943941, a NA study of Heart Failure, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to understand how the pressure in the pulmonary artery changes under different conditions of posture, respiration and exertion.
Primary Outcome
Posture defined as lying left side down compared to baseline supine
Conditions Studied
Interventions
- OTHER Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body.
Study Locations (2)
California
- University of California, San Francisco - San Francisco
Ohio
- The Lindner Research Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02943941 record still lists
NCT02943941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body. is the first listed.
NCT02943941 reports a single indexed study location in California, Ohio.
Frequently Asked Questions
What is clinical trial NCT02943941 about?
NCT02943941 is a clinical study titled "Pressure Variability Study". The purpose of this study is to understand how the pressure in the pulmonary artery changes under different conditions of posture, respiration and exertion.
What is the current status of trial NCT02943941?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-07. Estimated completion is 2017-01.
What conditions does trial NCT02943941 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02943941?
The interventions under investigation include: Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body. (OTHER).
Who is sponsoring clinical trial NCT02943941?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02943941 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02943941's enrollment target sits among peer trials
16 369th of 397 higher than 27 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia